36氪_让一部分人先看到未来

Since its establishment, Benyao Technology has completed several rounds of financing totaling hundreds of millions of yuan.

36Kr has learned that Benyao Technology has recently received hundreds of millions of yuan in the A3 round of financing. This round of financing is led by Panlin Capital, with Qiming Venture Capital and Boyuan Capital continuing to follow up. Since its establishment, Benyao Technology has completed multiple rounds of financing totaling hundreds of millions of yuan. The raised funds will be mainly used for the company's technology research and development, product development and production, market expansion, etc.

Benyao Technology was established in March 2021 and is committed to the intelligent automation transformation in the field of life sciences. It integrates cutting-edge robot technology, high-precision visual recognition and frontier artificial intelligence technology to provide intelligent automation products and solutions for various laboratories such as scientific research, clinical diagnosis and physicochemical applications. The founder and CEO, Tang Yang, once worked in the robot business department of ABB, one of the "Four Families" of international robots, and successively served as the president of the R & D center of ABB Robotics in China and the president of the consumer goods and service robot business unit of ABB Robotics in China.

In the traditional life science research and testing process, a large number of repetitive tasks such as manual liquid transfer, liquid preparation, and experimental record registration are used, resulting in low experimental efficiency and prone to errors in information. Especially after experiencing the COVID-19 pandemic, the demand for automation in the field of life sciences has been verified again.

Tang Yang mentioned that in the current wave of intelligent automation transformation in the life science industry, intelligent and automated technologies play a core driving force role. Benyao Technology hopes to liberate scientists from tedious and repetitive work by providing cutting-edge intelligent automation products and solutions, enabling them to focus on higher-level scientific research exploration and innovative practices.

It is reported that by integrating robot technology, high-precision visual recognition and frontier artificial intelligence technology, and relying on massive industry data and top algorithm models, Benyao Technology has developed an intelligent experimental robot with "domain cognition and reasoning type". Currently, the company has launched products including the general-purpose laboratory robot platform "LabGenius Laboratory Robot", the one-stop laboratory software platform "LabMind Laboratory Software", and the compact intelligent laboratory application platform "LabMate Laboratory Assistant", thereby meeting the intelligent automation needs of different scenarios.

Schematic diagram of Benyao Technology's laboratory automation products (Source: Benyao Technology)

It is worth mentioning that at the end of September this year, Benyao Technology just completed the new product iteration and released two industry-specific robot innovative products, the LabGenius G3 liquid transfer robot and the LabGenius S4 transfer robot. Taking the LabGenius G3 liquid transfer robot as an example, this product is intended to "create a zero-threshold use experience". It can meet the diverse needs of different customers for experiments by freely combining basic modules such as liquid transfer and force-position control grippers, and functional modules such as oscillation, heating oscillation, and temperature control, to achieve all-weather unmanned operation.

For example, methylation pretreatment is one of the application scenarios of the LabGenius G3 liquid transfer robot in the 细分领域. It can be used to complete the nucleic acid extraction of DNA samples, bisulfite conversion modification, and DNA magnetic bead purification after conversion, thereby providing methylation map analysis, tumor screening and risk assessment, early diagnosis, staging and typing, prognosis judgment and treatment monitoring for laboratory researchers or clinicians.

And the LabGenius S4 transfer robot is a high-speed, accurate, lightweight, small space-occupying, and easy-to-deploy compact transfer robot that can complete all-weather unmanned material transfer. It has advantages in improving experimental efficiency and ensuring sample safety. For example, it can maintain stable operation in case of abnormal power failure or emergency shutdown to ensure that the plates are not dropped and to prevent the waste of experimental samples and reagents.

It is also reported that in addition to small intelligent automation products, Benyao Technology has also laid out the business of large-scale intelligent automation customization. The company has now successfully implemented large-scale projects covering fields such as drug screening, synthetic biology, cell and gene therapy, omics research, applied chemistry, and clinical diagnosis.

Intelligent automation solutions of Benyao Technology (Source: Benyao Technology)

The information provided by Benyao Technology shows that the company has currently established subsidiaries in countries and regions such as Europe and the United States, covering thousands of customers in the fields of pharmaceuticals, materials, agriculture, clinical and government.

Investor Views:

Li Yuhui, the founding managing partner of Panlin Capital, said: "Laboratory automation is at a time of 'stock transformation' and 'incremental explosion', with a wide range of downstream application scenarios. The core team of Benyao Technology is deeply engaged in robot research and development, and at the same time has a deep background in the field of life sciences. On the basis of a full understanding of the automation needs, a feasible technology platform and a mature and reliable product system have been formed. Panlin firmly believes in the development trend of the deep integration and intersection of life sciences and automation, and looks forward to the company being able to use automation technology to help the industrial upgrading of life sciences."

Dr. Chen Kan, a partner of Qiming Venture Capital, said: "Since the first investment in Benyao Technology in 2021, we have seen the company continuously progress and evolve in underlying technology and product development, business expansion and team building. In the company's development process, we have also seen that users have a large number of and rich needs. These are the reasons why Qiming Venture Capital has repeatedly 追加投资 Benyao Technology. We firmly believe in the direction of laboratory automation and look forward to Benyao Technology being able to help the paradigm change in the life science industry."

Dr. Li Han, the executive director of Boyuan Capital, said: "Automation and intelligence are fundamentally changing the life science industry. Benyao Technology's series of products have become a powerful productivity tool to meet the high-efficiency and standardized needs of customers. Boyuan Capital believes that the company's products and business logic are highly competitive in the market. The more than one year after the investment has also witnessed the efficient execution and commercialization capabilities of the company's team. This round of continued investment in the company, and we look forward to Benyao Technology achieving excellent results in both the domestic and overseas markets in the future."

This article is originally produced by「胡香赟」， For reprint or content cooperation, please click Reprint Instructions ；Unauthorized reprint will be held accountable.